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Both administration of cardioplegic solution and blood reperfusion result 
in endothelial dysfunction. The transit rate of albumin microbubhles 
during myocardial contrast echocardiography may reflect endothelial in- 
jury. Accordingly, we performed myocardial contrast eehocardiography in 
12 dogs undergoing eardiopulmonary b pass and measured the myocardial 
transit rate of microbubbles injected into the aortic root during delivery 
of cardioplegic solutions containing arterial and venous blood and delivery 
of pure crystalloid cardioplegic solution. The myocardial transit rate of 
99mTc-labeled red blood cells was measured and perfusates were sampled 
for biochemical analysis at each stage. The microbubble transit rate was 
markedly prolonged uring delivery of crystalloid cardioplegic solution and 
improved significantly during infusion of blood cardioplegic solution (p < 
0.001); venous compared with arterial blood in the solution resulted in a 
greater rate (p < 0.001). The microbubble transit rate did not correlate 
with pH, oxygen tension or carbon dioxide tension values, or K + concen- 
tration. The red blood cell transit rate remained constant regardless of the 
cardioplegic perfusate infused. Myocardial contrast echocardiography was 
also performed in 12 patients undergoing coronary artery bypass who 
underwent sequential arterial and venous reperfusion after cardioplegic 
arrest. The microbubble transit rate was faster with venous than arterial 
blood reperfusion {p = 0.01), although this gain was diminished when 
arterial blood reperfusion preceded venous blood reperfusion (p = 0.05). 
Our results indicate that endothelial dysfunction after cardioplegic arrest 
may be ameliorated by reperfusion with venous rather than arterial blood. 
(J Thorac Cardiovasc Surg 1997;113:1100-8) 
A l though crystalloid cardioplegic solutions protect the myocardium during cardiopulmonary bypass 
(CPB), they can independently cause coronary mi- 
crovascular endothelial injury. 1-4 Abnormalit ies in 
endothelial function may occur even when the en- 
dothelium does not demonstrate any ultrastructural 
changes. 5 More profound functional and histologic 
injury may be seen after reperfusion, 4' 6, 7 which is 
largely attributable to cellular inflammatory re- 
sponses s and accumulation of oxygen-derived free 
radicals.V, 9-11 Addit ion of blood to cardioplegic so- 
lutions has been shown to reduce endothelial dam- 
age.l, s, a2, 13 During reperfusion, oxygen-derived 
free radicals are generated, and thus controlled 
reperfusion with gradual reoxygenation after CPB 
has been proposed to decrease ndothelial injury in 
previously hypoxic hearts, t4' 15 Because of the diffi- 
culty in assessing endothelial function, however, 
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Fig. 1. Illustration of method for obtaining time-intensity data during MCE. A contrast-enhanced l ft 
ventricular short axis image is shown with a region of interest placed over the anterior myocardium. The 
time-intensity plot from that region is shown at the right, and a y-variate function is fitted to the data after 
background subtraction to derive mean transit rate. See text for explanation of equation variables. 
studies designed to determine the effects of oxy- 
gen tension (Poe) during perfusion of blood car- 
dioplegic solution and reperfusion have been con- 
fined either to the evaluation of indirect indices of 
vascular function or to ex vivo microvascular 
preparations. 
Myocardial contrast echocardiography (MCE) 
has been used intraoperatively to assess myocardial 
perfusion. 16qs In intraoperative MCE, sonicated 
albumin microbubbles, which cause backscatter of 
ultrasound, are injected into the aortic root and 
their transit through the myocardium is recorded 
during simultaneously performed echocardiography. 
In a blood-perfused, beating heart, the rheologic 
features of sonicated albumin microbubbles are 
similar to those of red blood cells (RBCs). 19'2° 
During delivery of crystalloid cardioplegic solution, 
however, the transit of these microbubbles i mark- 
edly prolonged. Microvascular studies have sug- 
gested this effect may be caused by microbubble 
adherence to the venular endothelium, possibly 
reflecting endothelial injury. 2~ 
We hypothesized that, because of its low P02, 
venous blood would result in less microvascular 
injury on reperfusion compared with arterial blood 
and therefore its use would result in less prolonga- 
tion in the microbubble transit rate seen during 
MCE. We tested this hypothesis both in dogs and in 
patients undergoing coronary artery bypass. 
Methods 
Animal experimental preparation. The study protocol 
was approved by the animal research committee at the 
University of Virginia and conformed to the "Principles of 
Laboratory Care" formulated by the National Society for 
Medical Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources. Twenty-four male mongrel dogs 
were used in the study. Twelve of these dogs served as 
blood donors and the remaining 12 (mean weight 27 _+ 1 
kg) served as the study animals. These study dogs were 
anesthetized with 30 mg. kg -1 sodium pentobarbital nd 
intubated and the lungs mechanically ventilated with use 
of a respirator pump (model 607, Harvard Apparatus, 
South Natick, Mass.). Additional anesthesia was adminis- 
tered during the experiment as needed. Catheters were 
placed in the right femoral artery for pressure measure- 
ment and in the right femoral vein for administration of
fluids and drugs as needed. A median sternotomy was 
performed and the heart was suspended in a pericardial 
cradle. Heparin (300 U.  kg -1) was administered intrave- 
nously and supplemented very 90 minutes. 
The superior vena cava and right ventricle were cannu- 
lated transatrially. The left femoral artery was cannulated 
and CPB was instituted with use of a roller pump (model 
6002, Sarns Inc., Ann Arbor, Mich.) and a membrane 
oxygenator (American Bentley Corp., Irvine, Calif.). 
Blood flow through the pump was maintained at 2.0 to 3.0 
L. min  1 and the systemic blood temperature was main- 
tained at 37 ° C by means of a blood warmer (Blanketrol, 
Subzero Products Inc., Cincinnati, Ohio). An infusion 
catheter (DLP Inc.) was placed in the ascending aorta and 
its side arm was used to monitor aortic root pressure. The 
main port was connected via one arm of a Y connector to 
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Fig. 2. Patient study protocol. Patients were randomized to receive either arterial (group 1) or venous 
(group 2) blood first during reperfusion. 
a power injector (Angiomat 3000, Liebel-Flarsheim, Cin- 
cinnati, Ohio) for injection of microbubbles and radiola- 
beled RBCs. The other arm was used for delivery of 
perfusate at a constant rate of 150 ml .min  1 into the 
aortic root by means of a roller pump (model S 10K II, 
Sarns Inc.) connected to a mixing reservoir (model 
CPS4000, Gish Biomedical, Irvine, Calif.). This reservoir 
allowed for the constitution of different cardioplegic so- 
lution mixtures and contained a heating/cooling coil to 
maintain constant temperature. Arterial or venous blood 
from the bypass circuit was added to the reservoir via side 
limbs. A sampling port in the bottom of the chamber 
allowed collection of perfusate for analysis. 
All pressure lines were connected to a multichannel 
recorder (model 4568C, Hewlett-Packard, Andover, 
Mass.) via fluid-filled transducers (model 1295A, Hewlett- 
Packard). The surface electrocardiogram nd core body 
temperature were also monitored and recorded. 
Patient study. Twelve consecutive patients (10 men, 2 
women) referred for coronary artery bypass were included 
in the study. The study protocol was approved by the 
investigational review board at the University of Virginia 
and all patients gave written informed consent. Exclusion 
criteria were hypersensitivity to any blood product, prior 
coronary artery bypass, unstable operative hemodynamic 
condition, or more than mild aortic insufficiency on con- 
trast echocardiography. 
CPB was established after heparin administration (300 
U.  kg -a) with single right atrial and ascending aortic 
cannulation. The extracorporeal circuit comprised a 
heart-lung pump system (System 8000, Sarns Inc. and 
Bio-Medicus 540, Minneapolis, Minn.) placed in series 
with a hollow-fiber oxygenator with a closed venous 
reservoir (Univox, Baxter/Bentley, Irvine, Calif.) and an 
arterial line filter. Nonpulsatile flow rates from 2.5 to 5.0 
L .  min -1 were used in the extracorporeal circuit to main- 
tain mean systemic pressures greater than 60 mm Hg, and 
systemic temperatures were maintained between 25 ° and 
37 ° C. 
After the aorta was crossclamped, cardioplegia was 
achieved with use of a 1:1 dilution of oxygenated blood 
containing KC1 (20 mEq. L-1j and crystalloid cardioplegic 
solution (Plegisol, Abbott Laboratories. North Chicago, 
Ill., activated with 25 mEq- L -~ sodium bicarbonate) at a 
temperature of 6 ° to 8 ° C. The cardioplegic solution was 
administered in an anterograde fashion in all patients via 
an aortic root cannula (DLP) at an initial rate of 250 to 
400 ml. min 1 to achieve cardiac arrest. Additional car- 
dioplegic solution was administered after each graft anas- 
tomosis or if cardiac mechanical activity was visualized 
during the period of cardiac arrest. 
MCE. MCE was performed with a phased-array s stem 
(Sonos 2500, Hewlett-Packard) equipped with a 5 MHz 
transducer. A saline bath placed between the heart and 
the transducer was used as an acoustic interface in the 
canine studies. In patients, the transducer was placed in a 
sterile sleeve and positioned directly on the anterior 
cardiac surface. Images were acquired in the short-axis 
view at the mid-papillary muscle level. Gain settings were 
adjusted at the beginning of each experiment and were 
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Fig. 3. Examples of MCE time-intensity curves (top panel) and 99mTc-labeled RBC time-activity curves 
(bottom panel) from one dog. See text for details, cts, Counts. 
held constant hroughout. The maximal dynamic range 
(60 dB) was used. Images were recorded on 1.25 cm 
videotape at 30 Hz with use of a high-fidelity recorder 
(Panasonic AG6200, Matsushita Electric, Japan). 
Sonicated albumin microbubbles (Albunex, Molecular 
Biosystems Inc., San Diego, Calif.) with a mean size of 4.3 
/xm and a concentration of 0.5.109 m1-1 were used for 
MCE. In the animal studies, 1 to 1.5 ml of Albunex 
microbubbles diluted to a total volume of 2 ml with 0.9% 
NaC1 was used. In the human studies, 1.5 to 3.0 ml of 
Albunex microbubbles diluted to a total volume of 10 ml 
with 0.9% NaC1 was used. Microbubbles were power 
injected (Angiomat 3000, Liebel-Flarsheim, for animal 
studies and Mark 5-plus, MedRad, Pittsburgh, Pa., for 
human studies) into the aortic root via the DLP catheter 
at a rate of 5 ml • sec -1. 
Data were analyzed off-line with use of previously 
described algorithms. = Images encompassing the pe- 
riod from just before contrast injection until the disap- 
pearance of contrast from the myocardium were trans- 
ferred to the video memory of a computer (Mipron, 
Kontron Electronics, Eching, Germany) in a 244 × 
244 × 8 bit format. A region of interest was defined 
over a myocardial segment (but not over the anterior 
myocardium if a left internal thoracic graft was used) 
and the average videointensity in this region was mea- 
sured in every fifth frame (Fig. 1). The time-intensity 
data were background subtracted and fitted to a ?-vari- 
ate function: y = Ate -~t, whereA is a scaling factor, t is 
time, and a is the mean transit rate. = 
Radiolabeled RBC acquisition. 99mTc-labeled RBCs 
from the donor dog were used to measure the RBC transit 
rate. Approximately 0.1 mCi of labeled RBCs was diluted 
to a total volume of 2 ml and injected into the aortic root 
via the DLP catheter at a rate of 5 ml.  sec -1. Radioactivity 
within the myocardium was measured with use of a 
miniature cesium iodide probe (Oxford Instruments, Ox- 
ford, England) equipped with a converging collimator 
placed 3 cm above the anterior cardiac surface. The 
photodiode of the probe was connected to a preamplifier- 
amplifier unit designed specifically to detect the 99mTc 
photopeak. Data were acquired at a sampling rate of 2 Hz 
and transferred to a personal computer (model 310, Dell 
Computer Corp., Austin, Tex.). Time activity data were 
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Fig. 4. Mean (plus or minus standard error of the mean) 
microbubble transit rates from all 12 dogs during perfu- 
sion with various cardioplegic solutions. *p < 0.05 com- 
pared with all other data points. 
fitted to a y-variate function and, similar to the method of 
MCE analysis, c~ corresponded to the mean transit rate. 
Animal protocol. After the aorta was crossclamped, 
arterial blood containing KC1 (20 mEq. L -1) was admin- 
istered through the aortic root at a rate of 150 ml. min -~ 
for approximately 2 minutes to achieve cardiac arrest. 
MCE and labeled RBC data were acquired in random 
order approximately 1 minute after cardiac arrest was 
achieved, and blood was obtained from the mixing cham- 
ber for analysis of K ÷ concentration, osmolality, pH, and 
Po2 and carbon dioxide tension (Pco2) values. The cross- 
clamp was removed and similar steps were repeated with 
venous blood and arterial blood and with crystalloid 
cardioplegic solution (Plegisol) in a random order. Crys- 
talloid cardioplegic solution was activated before use by 
addition of 20 ml. L -~ of 8.4% NaHCO3, and supplemen- 
tal KC1 was added to each perfusate as needed to maintain 
concentrations of approximately 20 mEq. L -1. 
Human experimental protocol. The protocol for the 
human studies is depicted in Fig. 2. After completion of 
the final graft anastomosis, the heart was reperfused at a 
constant flow rate for 60 seconds with normothermic 
arterial or venous blood, as randomly assigned. MCE was 
performed approximately 30 seconds after reperfusion 
and sample s were taken from a side arm of the perfusion 
line to measure K ÷ and total protein concentrations, pH, 
Po 2 and Pco 2 values, and hematocrit level. The perfusate 
was then switched to the alternate blood composition 
(arterial or venous) for 60 seconds and both MCE and 
sampling of the perfusate were repeated. 
Statistical methods. Data were analyzed with RS/1 and 
SAS programs and are expressed as the mean plus or 
minus 1 standard eviation unless otherwise specified. In 
animals, comparisons between mean transit rates for 
different perfusates and comparisons between perfusate 
variables were made with repeated-measures analysis of 
variance. In patients, comparisons of MCE data between 
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Fig. 5. 99mTc-labeled RBC transit rates from all 12 dogs 
during perfusion with various cardioplegic solutions. 
arterial and venous perfusion were made with the Wil- 
coxon signed-rank test. Interval comparisons were made 
with the unpaired Student's t test. 
Results 
Animal studies. Il lustrated in the foppanel of Fig. 
3 are examples from one dog of background-sub- 
tracted time-intensity curves obtained with MCE 
during perfusion with various cardioplegic solutions. 
Microbubbles persisted in the myocardial microcir- 
culation during delivery of crystalloid cardioplegic 
solution, which resulted in a wide curve and a slow 
mean transit rate. During infusion of blood car- 
dioplegic solution, the transit rate increased, as 
reflected by a narrowing of the time-intensity curves, 
and was faster with venous compared with arterial 
blood cardioplegic solution. The transit rate of 
labeled RBCs was not prolonged during crystalloid 
cardioplegic solution delivery and remained con- 
stant during infusion of the blood-containing perfu- 
sates, as illustrated by the similar time-activity 
curves in the bottom panel of Fig. 3. 
MCE data from all 12 dogs paralleled the findings 
in the example discussed in the previous paragraph 
and are shown in Fig. 4. During delivery of crystal- 
loid cardioplegic solution, persistence of micro- 
bubbles in the myocardium resulted in a slow transit 
rate. The microbubble transit rate was significantly 
increased during delivery of arterial blood car- 
dioplegic solution. Deoxygenated venous blood car- 
dioplegic solution resulted in an even faster transit 
rate. Radiolabeled RBC transit rates (Fig. 5) were 
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similar with crystalloid, arterial blood, and venous 
blood cardioplegic solutions. 
Hemodynamic and biochemical variables mea- 
sured for each perfusate are presented in Table I. 
There were no statistically significant differences in
the aortic root pressure, coronary vascular esis- 
tance, K ÷ concentration, osmolality, pH, Pco2 level, 
or perfusate temperature. Significant differences in
the Po2 values were found among all three perfu- 
sates. Normal sinus rhythm before aortic cross- 
clamping and cardioplegic solution delivery oc- 
curred in 40%, 36%, and 27% of the animals for 
stages that used arterial blood, venous blood, and 
pure crystalloid cardioplegic solution, respectively 
(p = 0.39). 
Patient studies. Demographic and clinical data 
are presented in Table II. The characteristics of
patients who received arterial blood reperfusion first 
were similar to those of patients who received 
venous blood reperfusion first, with the exception of 
a longer aortic crossclamp time in the former. 
MCE transit rate data for all 12 patients are 
illustrated in Fig. 6. Regardless of the sequence of 
reperfusion, venous blood resulted in faster transit 
rates compared with those for arterial blood in all 
patients. The mean microbubble transit rate was 
0.97 _+ 0.39 sec -~ during arterial blood perfusion and 
1.78 +_ 0.71 sec -1 during venous blood perfusion 
Q) = 0.01). Venous blood resulted in a faster transit 
rate when given before arterial blood (group 2), 
although this finding was of borderline significance 
(p = 0.05). No relationship was found between the 
MCE transit rate and perfusate sequence (that is, 
between first and second blood perfusate). Compar- 
ison of the chemical analysis of the perfusates i
shown in Table III. Both the pH and Po2 values 
were lower in venous compared with arterial blood. 
Discussion 
In our canine model of CPB, we have demon- 
strated that sonicated albumin microbubbles persist 
in the myocardium during administration f crystal- 
told cardioplegic solution. RBC transit rates during 
delivery of crystalloid cardioplegic solution, how- 
ever, remain unaltered compared with those during 
blood cardioplegic solution delivery, which suggests 
that the persistence of the MCE contrast effect 
reflects a specific and unique interaction between 
microbubbles and the microvascular endothelium. 
The use of blood-containing cardioplegic perfusates 
improved the transit rate and a greater effect was 
observed with venous than with arterial blood. Sim- 
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Fig. 6. Microbubble transit rates obtained from patients 
during arterial and venous blood reperfusion after car- 
dioplegic arrest. 
ilar results were found in patients undergoing reper- 
fusion after cardioplegic arrest and CPB. 
Endothelial injury during cardioplegic arrest and 
reperfusion. Reperfusion of ischemic myocardium 
results in functional impairment of the vascular 
endothelium, which is most marked in vessels 
smaller than 200 p~m. 23 These abnormalities may 
occur even in the absence of histologic evidence of 
injury, 9'23 although findings of endothelial cell 
edema or disruption are not uncommon and may be 
related to the length of time after reperfusion, l°' 24 
Cardioplegic solutions that are used during CPB for 
myocardial protection do not prevent the injury that 
occurs after reperfusion.*' 6, 7 Moreover, the admin- 
istration of these solutions themselves has been 
shown to cause some degree of endothelial dysfunc- 
tion.i, 2 The detection of endothelial dysfunction i
the setting of cardioplegic arrest is difficult and 
relies on microvascular p eparations, i olated heart 
models, or indirect serologic indices of injury. 
Initial observations with MCE in our laboratory 
suggested that myocardial opacification caused by 
sonicated albumin microbubbles persisted for a long 
duration during infusion of crystalloid cardioplegic 
solution.16, 17 Normally, these bubbles posses s simi- 
lar rheologic properties to those of RBCs and pass 
unencumbered through the microcirculation. .9' 2o In 
the current study, the mean microbubble transit rate 
was abnormally prolonged during crystalloid car- 
dioplegic solution administration, yet the RBC tran- 
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Table I. Variables measured uring administration of different cardioplegic perfusates in 12 dogs 
Crystalloid cardioplegic Arterial Venous p 
solution blood blood Value 
Aortic root pressure (mm Hg) 54 _+ 15 46 _+ 10 45 _+ 13 0.16 
Coronary vascular esistance (dynes • sec • cm s). 26,412 ± 9266 22,070 ± 7054 21,708 ± 6547 0.25 
K ÷ (mEq • L -1) 24.4 ± 3.1 24.2 ± 6.2 26.8 + 2.3 0.13 
Osmolality (mOsm • kg -1) 315 ± 12 320 ± 10 327 ± 15 0.I0 
pH 7.49 ± 0.22 7.54 -+ 0.08 7.50 -+ 0.06 0.07 
Po 2 (mm Hg) 158 ± 75 386 ± 110 43 ± 13 <0;001 
Pco2 (mm Hg) 15 ± 5 14 ± 2 17 ± 3 0.12 
Temperature (°C) 22 ± 12 25 ± 11 25 _+ 1t 0.80 
*Calculated by the formula (aortic pressure)(1332 dynes • cm -2 • mm Hg)(60 sec- min-1)/(infusion rate). 
Table II. Demographic and clinical data in patients 
receiving arterial-venous or venous-arterial 
reperfusion 
Arterial- Venous- 
venous arterial p 
(n = 6) (n - 6) Value 
Age (median, yr) 68 64 0.08 
Weight (kg) 77 -+ 18 85 _+ 14 0.39 
Body surface area (m a) 1.9 _+ 0.2 2.0 ± 0.1 0.27 
Cardioplegic solution 1975 ± 189 1997 _+ 316 0.92 
dose (ml)* 
CPB time (min) 97 _+ 17 78 ± 21 0.11 
Aortic crossclamp time 62 ± 8 49 _+ 11 0.03 
(min) 
Bypassed vessels 3.5 3.0 0.29 
(median, n) 
*(Blood cardioplegic solution flow rate) × (total time of cardioplegic 
solution administered). 
sit rate remained normal, indicating that these bub- 
bles might either interact with the myocardial 
microvasculature in this setting or rely on blood to 
facilitate their circulatory transit. The former hy- 
pothesis is supported by previous intravital micro- 
scopic observations that some of the albumin micro- 
bubbles injected intravascularly adhere to venular 
endothelium after cardioplegic solution delivery and 
reperfusion. 21 Instead of behaving like RBCs, these 
bubbles behaved like leukocytes, which were also 
seen adhering to the endothelium asa consequence 
of endothelial injury, aj We believe that endothelial 
adherence of the microbubbles in response to car- 
dioplegia-induced injury resulted in a prolonged 
myocardial microbubble transit rate in our study. 
We have previously shown that adherence of only a 
relatively small proportion of the albumin micro- 
bubbles injected is needed to produce the persistent 
myocardial opacificationY Physical entrapment of
the microbubbles, caused by changes in microcircu- 
latory dimension, can be excluded as a reason for 
Table III. Analysis of arterial and venous perfusates 
in patients during reperfusion 
Arterial Venous p 
(n = 12) (n = 12) Value 
Hematocrit (%) 18.0 ± 4.3 15.8 +_ 3.3 0.07 
Potassium concentration 9.9 _+ 2.7 7.3 _ 3.6 0.08 
(mEq" L -1) 
pH 7.31 + 0.03 7.14 ± 0.08 <0.001 
P% (ram Hg) 151 _+ 38 48 _+ 4 <0.001 
Pco2 (mm Hg) 39 + 3 44 -+ 11 0.10 
persistent myocardial opacification because both the 
RBC transit rates and coronary vascular esistance 
values were similar between perfusate groups. 
Role of blood during cardioplegie arrest. Most of 
the injury after cardioplegic arrest is thought o 
occur after reperfusion 6'7 and results from the 
release of multiple cytotoxic factors. Oxygen-de- 
rived free radicals are one of many leukocyte- 
derived chemical mediators of endothelial injury. 11 
Because injury resulting in endothelial dysfunction 
may occur early after reperfusion, 9' 10 sources of 
reactive oxygen intermediates other than leukocytes 
may be more important; these include calcium- 
dependent xanthine oxidase production of 02- and 
H20226 and generation of peroxynitrite from excess 
nitric oxide production. 27The microcirculatory en- 
dothelium isextremely sensitive to these compounds 
and functional abnormalities are seen very early 
after exposure to oxygen free radicals. 9-11 
The use of blood cardioplegia has been shown to 
preserve endothelial integrity and function 5'13 
rather than to cause the deleterious effects that are 
seen after sudden reperfusion. The beneficial effect 
of blood may be independent of its oxygen-carrying 
capacity because of a leftward shift of the oxygen- 
hemoglobin dissociation curve. 2s Only dissolved 
rather than hemoglobin-bound oxygen is delivered 
to the tissue. That the Po 2 level of the perfusate in 
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the animal protocol had no relation to the micro- 
bubble transit rate in our study also suggests hat the 
beneficial effect of blood may be independent of 
oxygen delivery. Furthermore, when results of 
reperfusion with only arterial and venous blood 
were compared in patients, we found an inverse 
correlation between P02 values and the microbubble 
transit rate during reperfusion. 
The beneficial effect of blood in cardioplegic 
solution may instead be a result of its action as a 
scavenger of oxygen-derived free radicalsJ 3 The 
addition to cardioplegic solutions of other scavenger 
compounds and inhibitors of free radical production 
has been observed to have similar effects. 7' 9, 10 The 
lower oxygen content and possibly better free-radi- 
cal scavenging properties of venous blood during 
cardioplegia may have produced less endothelial 
injury and, hence, faster microbubble MCE transit 
rates. In patients, we found that reperfusion with 
venous blood resulted in more rapid microbubble 
transit han reperfusion with superoxygenated arte- 
rial blood. That faster transit rates with venous 
blood are caused by less endothelial injury is com- 
mensurate with observations in hypoxic animals in 
which use of hyperoxic ardioplegic or reperfusion 
solutions resulted in oxidative injury. 14' 12 The limi- 
tation of oxygen delivery by use of venous blood has 
also been shown to reduce free radical-mediated 
reperfusion injury in the rat intestine. 29Hypoxic 
reperfusion of isolated skeletal muscles after isch- 
emia has been shown to attenuate the increase in 
vascular resistance and permeability, 3° thereby sup- 
porting the theory that endothelial injury can be 
lessened with low P02 reperfusion. The finding that 
venous blood was less beneficial when its use was 
preceded by use of arterial blood implies that reper- 
fusion damage may be cumulative, although this 
conclusion is somewhat confounded by the longer 
crossclamp time in this group. 
Study limitations. Although evidence in this and 
other studies upports the notion that microbubbles 
adhere to injured endothelium, 21 the mechanism of
this interaction remains unclear. Because prolonga- 
tion of the MCE transit rate during delivery of 
crystalloid cardioplegic solution can be rapidly re- 
versed, the mechanism probably does not involve 
severe structural alteration of the endothelium or 
immediate xpression of adhesion molecules. The 
rapid reversal would, rather, imply a more dynamic 
process that may involve either the endothelial 
glycocalyx or preexisting cell surface molecules, 
which are altered under various pathologic states. 
Further investigation will be needed to determine 
the cause of such interactions wherein the causal 
relationship between oxidative injury and micro- 
bubble adherence may be established by the addi- 
tion of inhibitors of free radical formation and 
measurement of venous effluent oxidative metabo- 
lites such as conjugated dienesJ s Elucidation of the 
mechanisms ofmicrobubble adherence tothe endo- 
thelium would also offer insight into the beneficial 
properties of blood compared with crystalloid solu- 
tions during cardioplegic arrest. Because all patients 
in the intraoperative portion of the study received 
both arterial and venous reperfusion, comparison of 
effects on left ventricular function and on long-term 
clinical outcomes was not possible but could be 
investigated in future studies. 
Defined normal values do not exist for the myo- 
cardial transit rates of microbubbles and RBCs 
because these parameters are influenced by the 
input function, which is determined by both the site 
and rate of injection. We held all of these variables 
constant, as well as the myocardial blood/cardiople- 
gic solution flow rate, which could also alter micro- 
bubble transit rate. The transit rate is also inversely 
proportional to the volume of distribution within the 
myocardium 21 and, although we could not indepen- 
dently confirm that myocardial blood volume was 
constant, similar coronary vascular resistance values 
during different infusions would suggest hat such 
was the case. 
Clinical applications. The evaluation of MCE 
transit rates has the potential to directly assess 
endothelial function under various conditions. With 
this technique, we have demonstrated that the use of 
venous rather than arterial blood may be advanta- 
geous for reperfusion after cardioplegic arrest. 
These results have an important bearing on the 
determination f optimal cardioplegic solution com- 
position during coronary artery bypass procedures. 
Further studies are required to understand the 
mechanisms of the interaction between micro- 
bubbles and the endothelium. 
We are grateful to Danny M. Skyba, PhD, and Ananda 
R. Jayaweera, PhD, for their technical assistance. 
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